disclaimer i want make absolutely clear i alleging crime committed regarding label marketing i discuss one famous zyprexa documents provide opinion implications i document titled zyprexa primary care strategy implementation overview authored mike bandick brand manager zyprexa emphases document mine unless noted document states position zyprexa safe proven solution mood thought behavior disorders emphasis original emphasize safety address barriers adoption merchandise brand four years four million patients base experience word solution speaks unmet medical need enables pcp take control clinical situations previously led referrals poor outcomes mental disorders intentionally broad vague providing latitude frame discussion around symptoms behaviors rather specific indications position zyprexa incremental next step pcp expanding clinical orbit ssri nd generation antidepressants safe gentle psychotropics later document stated zyprexa pcp strategy designed fit within brand vision broad spectrum efficacy number important points discussion intentionally broad vague marketing zyprexa provides latitude frame discussion around symptoms behaviors rather specific indications points lilly apparently marketing zyprexa label ties another document pointed toward zyprexa possibly marketed conditions schizophrenia bipolar disorder see post pcps see patients schizophrenia bipolar disorder especially bipolar i much impairing bipolar ii certain see patients symptoms behaviors may overlap schizophrenia bipolar example perhaps male patient unusually energetic irritable yet way resembles individual bipolar disorder individual unmet medical need zyprexa perhaps patient need medication provides broad spectrum efficacy across wide variety symptoms behaviors opposed specific indications empowering pcp also note lilly appears positioning zyprexa incremental next step pcp expanding clinical orbit first pcps prescribing antidepressants generally ssris pcps perhaps empowered ability prescribe atypical antipsychotics zyprexa case degree comfort prescribe drug course inference seem concerted effort make pcps feel comfortable prescribing zyprexa opposed making mental health specialty referrals safe proven solution mood thought behavior disorders reiterate type slogan really lends label marketing i think reason lilly could instead used following safe proven solution schizophrenia bipolar disorder issue safe assertion also questioned dislaimer case read first one please note i equipped state whether lilly marketing practices regarding zyprexa illegal law seems pretty unclear point course whether practice legal whether ethical two different things document discussed post document number available furious seasons